Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 2, 1998, Pages 539-544

  Lee, Kirby ^a   Kornetsky, Conan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; ICSS; Reward; Self stimulation; Serotonin; Substance abuse

Indexed keywords

DOPAMINE; FLUOXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG ABUSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD; VENTRAL TEGMENTUM;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; FLUOXETINE; MALE; MEDIAL FOREBRAIN BUNDLE; RATS; RATS, WISTAR; REWARD; SELF STIMULATION; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 0032100554     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00020-3     Document Type: Article

References (52)

1. Andreev B.V. Effect of choline and serotonergic substances on self-stimulation in rats. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni IP Pavlova. 29:1979;353-357.
2. Bose S., Bailey P.T., Nguyen B.T., Pradhan S.N. Effects of 5-hydroxy-tryptophane on self-stimulation in rats. Psychopharmacologia. 36:1974;255-262.
3. Caccia S., Cappi M., Fracasso C., Garattini S. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology. 100:1990;509-514.
4. Carter C.J., Pycock C.J. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Life Sci. 23:1978;953-960.
5. Cazala P. Effects of Lilly 110140 (Fluoxetine) on self-stimulation behavior in the dorsal and ventral regions of the lateral hypothalamus in the mouse. Psychopharmacology. 71:1980;143-146.
6. Clark R.N., Ashby C.R. Jr., Dewey S.L., Ramachandran P.V., Strecker R.E. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse. 23:1996;125-131.
7. Esposito R.U., Motola A.H.D., Kornetsky C. Cocaine. Acute effects on reinforcement thresholds for self-stimulation behavior to the medial forebrain bundle Pharmacol. Biochem. Behav. 8:1978;437-439.
8. Fibiger H.C. Drugs and reinforcement mechanisms. A critical review of the catecholamine theory Annu. Rev. Pharmacol. Toxicol. 18:1978;37-56.
9. Fibiger H.C., Phillips A.G. Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science. 214:1981;683-685.
10. Fiorino D.F., Coury A., Fibiger H.C., Phillips A.G. Electrical stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus accumbens of the rat. Behav. Brain. Res. 55:1993;131-141.
11. Fletcher P.J. Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward. Psychopharmacology. 126:1996;62-69.
12. Fletcher P.J., Tampakeras M., Yeomans J.S. Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol. Biochem. Behav. 52:1995;65-71.
13. Frankfurt M., McKittrick C.R., Luine V.N. Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei. Brain Res. 650:1994;127-132.
14. Gardier A.M., Lepoul E., Trouvin J.H., Chanut E., Dessalles M.C., Jacquot C. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment. Relationship with brain concentrations of fluoxetine and norfluoxetine Life Sci. 54:1993;51-56.
15. Gerson S.C., Baldessarini R.J. Motor effects of serotonin in the central nervous system. Life Sci. 27:1980;1435-1451.
16. Goldman M.J., Grinspoon L., Hunter-Jones S. Ritualistic use of fluoxetine by a former substance abuser [letter]. Am. J. Psychiatry. 147:1990;1377.
17. Guan X.M., McBride W.J. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res. Bull. 21:1988;43-46.
18. Guan X.M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res. Bull. 23:1989;541-547.
19. Hammer R.P. Jr., Margulies J.E., Lynn A.B., Brady L.S. Chronic fluoxetine treatment upregulates dopamine receptors in the mesolimbic forebrain of the rat. Depression. 1:1993;82-87.
20. Hollister A.S., Breese G.R., Kuhn C.M., Cooper B.R., Schanberg S.M. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine. J. Pharmacol. Exp. Ther. 198:1976;12-22.
21. Hubner C.B., Kornetsky C. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J. Pharmacol. Exp. Ther. 260:1992;562-567.
22. Ichikawa J., Meltzer H.Y. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur. J. Pharmacol. 281:1995;255-261.
23. Izenwasser S., Kornetsky C. Brain-stimulation reward. A method for assessing the neurochemical bases of drug-induced euphoria Watson R.R. Drugs of abuse and neurobiology. 1992;1-21 CRC Press, Boca Raton, FL.
24. Katz R.J., Carroll B.J. Intracranial reward after Lilly 110140 (fluoxetine HCL). Evidence for an inhibitory role for serotonin Psychopharmacology. 51:1977;189-193.
25. Koob G.F. Dopamine, addiction and reward. Semin. Neurosci. 4:1992;139-148.
26. Koob G.F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13:1992;177-184.
27. Kornetsky C., Bain G. Brain-stimulation reward. A model for drug-induced euphoria Adler M.W., Cowan A. Modern methods in pharmacology testing and evaluation of drugs of abuse, vol. 6. 1990;211-231 Wiley, New York.
28. Kornetsky C., Esposito R.U. Euphorigenic drugs. Effects on the reward pathways of the brain Fed. Proc. 38:1979;2473-2476.
29. Kornetsky C., Esposito R.U., McLean S., Jacobson J.O. Intracranial self-stimulation thresholds. A model for the hedonic effects of drugs of abuse Arch. Gen. Psychiatry. 36:1979;289-292.
30. Kornetsky C., Porrino L.J. Brain mechanisms of drug-induced reinforcement. O'Brien C.P., Jaffe J.H. Addictive states. 1992;59-77 Raven Press, Ltd, New York.
31. Kreiss D.S., Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274:1995;866-876.
32. Layer R.T., Uretsky N.J., Wallace L.J. Effect of serotonergic agonists in the nucleus accumbens on d-amphetamine-stimulated locomotion. Life Sci. 50:1992;813-820.
33. Markou A., Koob G.F. Construct validity of a self-stimulation threshold paradigm. Effects of reward and performance manipulations Physiol. Behav. 51:1992;111-119.
34. Matthews K., Baldo B.A., Markou A., Lown O., Overstreet D.H., Koob G.F. Rewarding electrical brain stimulation. Similar thresholds for flinders sensitive line hypercholinergic and flinders resistant line hypocholinergic rats Physiol. Behav. 59:1996;1155-1162.
35. McCarter B.D., Kokkinidis L. The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats. Pharmacol. Biochem. Behav. 31:1988;243-247.
36. Messing R.B., Phebus L., Fisher L.A., Lytle L.D. Effects of p-Chloroamphetamine on locomotor activity and brain 5-hydroxyindoles. Neuropharmacology. 15:1976;157-163.
37. 1A agonists and dopamine. The effects of 8-OH-DPAT and buspirone on brain-stimulation reward J. Neural Transm. 83:1991;139-148.
38. Muscat R., Mariusz P., Willner P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology. 109:1992;433-438.
39. Parsons L.H., Justice J.B. Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606:1993;195-199.
40. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego, CA.
41. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50:1992;1683-1690.
42. Plaznik A., Stefanski R., Palejko W., Bidzinski A., Kostowski W., Jessa M., Nazar M. Antidepressant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Pharmacol. Biochem. Behav. 48:1994;315-325.
43. Redgrave P., Horrell R.I. Potentiation of central reward by localized perfusion of acetylcholine and 5-hydroxytryptamine. Nature. 262:1976;305-307.
44. Rodriguez Echandia E.L., Broitman S.T., Foscolo M.R. Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats. Pharmacol. Biochem. Behav. 19:1983;193-197.
45. Ross S.B., Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxy-tryptamine in brain tissue. Eur. J. Pharmacol. 7:1969;270-277.
46. Sarkar M., Kornetsky C. Methamphetamine's action on brain-stimulation reward threshold and stereotypy. Exp. Clin. Psychopharmacol. 3:1995;112-117.
47. Tinsley J.A., Olsen M.W., Laroche R.R., Palmen M.A. Fluoxetine abuse. Mayo Clinic Proc. 69:1994;166-168.
48. Valentino D.A., Riccitelli A.J., Dufresne R.L. Chronic DMI reduces thresholds for brain stimulation reward in the rat. Pharmacol. Biochem. Behav. 39:1991;1-4.
49. Wise R.A., Bauco P., Carlezon W.A., Trojniar W. Self-stimulation and drug reward mechanisms. Ann. NY Acad. Sci. 654:1992;192-198.
50. Wong D.T., Bymaster F.P. Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors Adv. Exp. Med. Biol. 363:1995;77-95.
51. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin reuptake inhibitor and an antidepressant drug. Twenty years since its first publication Life Sci. 57:1995;411-441.
52. Wong D.T., Horng J.S., Bymaster F.P., Hauser K.L., Molloy B.B. A selective inhibitor of serotonin uptake. Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine Life Sci. 15:1974;471-479.